Yendamuri S, Swisher SG , Correa AM, Hofstetter W, Ajani JA, Francis A, Maru D, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA
Correlation of pretreatment p63-positive subtype of gastroesophageal adenocarcinoma (GEAC) with pathologic complete response (pathCR) in patients receiving preoperative chemoradiation
PMID: 32026278
Brimonidine reduces production and increases outflow plus possible neuroprotective effects
Segundo uma reviso de artigos tambm publicada pela Revista de Nutrio, a substncia pode ser prescrita para alguns pacientes portadores de doenas renais e hepticas que possuem a produo reduzida de L-carnitina no organismo, por conta do mal funcionamento desses rgos
This test identifies which genetic variants may drive appetite rebound in your case and informs whether continuous therapy, dose optimization, or combination protocols best align with your biology